发明名称 |
BTLA FUSION PROTEIN AGONISTS AND USES THEREOF |
摘要 |
The present invention is based on the seminal discovery that BTLA agonist fusion proteins modulate an immune response. Specifically, the present invention provides fusion proteins that bind BTLA enhancing BTLA signaling. The present invention further provides methods of treating cancer and immune and inflammatory diseases and disorders with a BTLA agonist fusion protein as described herein. |
申请公布号 |
WO2017004213(A1) |
申请公布日期 |
2017.01.05 |
申请号 |
WO2016US40108 |
申请日期 |
2016.06.29 |
申请人 |
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE |
发明人 |
WARE, Carl, F.;SEDY, John |
分类号 |
C07K14/705;A61K38/17;A61K45/06 |
主分类号 |
C07K14/705 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|